tiprankstipranks
Trending News
More News >
Black Diamond Therapeutics (BDTX)
NASDAQ:BDTX
US Market

Black Diamond Therapeutics (BDTX) Income Statement

Compare
1,599 Followers

Black Diamond Therapeutics Income Statement

Last quarter (Q4 2025), Black Diamond Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Black Diamond Therapeutics's net income was $-15.12M. See Black Diamond Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 70.00M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 69.67M$ 0.00$ -437.00K$ 0.00$ 0.00
Operating Expenses
$ 49.80M$ 78.78M$ 86.02M$ 92.83M$ 126.87M
Depreciation and Amortization
$ 325.00K$ 343.00K$ 437.00K$ 508.00K$ 205.00K
EBITDA
$ 20.20M$ -78.44M$ -86.02M$ -92.32M$ -126.67M
Operating Income
$ 19.87M$ -78.78M$ -86.46M$ -92.83M$ -126.87M
Other Income/Expenses
$ 2.50M$ 9.11M$ 4.02M$ 1.66M$ 1.28M
Pretax Income
$ 22.37M$ -69.68M$ -82.44M$ -91.17M$ -125.60M
Net Income
$ 22.37M$ -69.68M$ -82.44M$ -91.17M$ -125.60M
Per Share Metrics
Basic EPS
$ 0.39$ -1.27$ -1.88$ -2.52$ -3.47
Diluted EPS
$ 0.39$ -1.27$ -1.88$ -2.52$ -3.47
Weighted Average Shares Outstanding
56.87M 55.03M 43.95M 36.23M 36.19M
Weighted Average Shares Outstanding (Diluted)
57.56M 55.03M 43.95M 36.23M 36.19M
Currency in USD

Black Diamond Therapeutics Earnings and Revenue History